[AKRO] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -1,690.40%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -151,759 -112,033 -100,777 -79,207 -43,755 -81,714 -4,564 79.27%
Tax 0 -3,123 -41 -17 24 -68,097 -4,979 -
NP -151,759 -108,910 -100,736 -79,190 -43,755 -81,714 -4,564 79.27%
Tax Rate - - - - - - - -
Total Cost 151,759 108,910 100,736 79,190 43,755 81,714 4,564 79.27%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -2.89 -2.79 -2.89 -2.52 -2.90 -3.85 -0.16 61.94%
EPS Diluted -2.89 -2.79 -2.89 -2.52 -2.90 -3.85 -0.16 61.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.